Cavalier Jason 4
4 · Lyra Therapeutics, Inc. · Filed Oct 18, 2024
Insider Transaction Report
Form 4
Cavalier Jason
Chief Financial Officer
Transactions
- Award
Common Stock
2024-10-16+100,000→ 100,000 total
Footnotes (1)
- [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in three substantially equal installments occurring on April 1, 2025, October 1, 2025 and April 1, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.